41.30000 EUR
0.6
1.43%
Last update Dec 9, 9:30 PM CET
Main market
Day range
41.30000
41.30000
Previous close
41.90000
Open
41.30000
Access this stock data via API
Subscribe
Soleno Therapeutics Inc.
41.30
0.60
1.43%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 56.3M 27.8M 0 0
Cost of revenue 972.7K 593.3K
Gross profit 55.3M 27.2M
Operating expense
Research & development 7.2M 7.8M 11.5M 18.3M
Selling general and admin 28.8M 24.1M 24.9M 31.8M
Other operating expenses
Operating income 19.4M -4.6M -36.5M -50.1M
Non operating interest income
Income 4.5M 2.7M 2.8M 2.9M
Expense 1.2M 1.2M 1.2M
Other income expense -523.4K -938.6K -2.5M -278.8K
Pretax income 22.2M -4.0M -37.3M -47.7M
Tax provision
Net income 22.2M -4.0M -37.3M -47.7M
Basic EPS -0.1 -1.0 -1.3
Diluted EPS -0.1 -1.0 -1.3
Basic average shares 43.0M 39.4M 37.4M
Diluted average shares 43.0M 39.4M 37.4M
EBITDA 24.3M -1.5M -33.2M -41.9M
Net income from continuing op. 22.2M -4.0M -37.3M -47.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 26 minutes

19:33
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).